Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic's C1 Gene Expression Platform
Stock Information for Dyadic International Inc.
Loading
Please wait while we load your information from QuoteMedia.